NorthWest Biotherapeutics Inc (NWBO)

[Roman516]

The press release from 10/5/20 was light years ago with respect to all the recent and more positive attributes associated to NWBO. Case in point, the current accomplishments regarding the data results from the 5/10/22 presentation.
"Presentation About Phase 3 Trial of DCVax®-L for Glioblastoma To Be Made At New York Academy Of Sciences." However, lies and deceptive individuals and media cause NWBO's SP to tank, and then months later redact their works to CYA, but could be still liable for their initial lies and deceptive media comments?

The fact is that DCVax-L works but there are paid individuals who will continue to make up anything to contradict the facts. They will use outdated risk factors based on old information; they will twist their stories no matter what. Again, the facts are clear, and NWBO will persevere and be able to help many cancer patients who are the ones that will benefit from DCVax-L.